gemcitabine has been researched along with sphingosine in 1 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (100.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bousquet, C; Brizuela, L; Cuvillier, O; Davenne, L; Delisle, MB; Guilbeau-Frugier, C; Guillermet-Guibert, J; Pchejetski, D; Saint-Laurent, N; Susini, C | 1 |
1 other study(ies) available for gemcitabine and sphingosine
Article | Year |
---|---|
Targeting the sphingolipid metabolism to defeat pancreatic cancer cell resistance to the chemotherapeutic gemcitabine drug.
Topics: Blotting, Western; Cell Proliferation; Cell Survival; Ceramides; Deoxycytidine; Drug Resistance, Neoplasm; Enzyme Inhibitors; Gemcitabine; Humans; Lysophospholipids; Pancreatic Neoplasms; Phosphotransferases (Alcohol Group Acceptor); Reverse Transcriptase Polymerase Chain Reaction; Ribonucleotide Reductases; RNA, Messenger; Sphingosine; Tumor Cells, Cultured | 2009 |